# MChepato
This repository contains the code and the synthetic data used for:

**"Diffusion MRI signal cumulants and hepatocyte microstructure at fixed diffusion time: Insights from simulations, 9.4T imaging, and histology"**. *Grussu F, Bernatowicz K, Casanova-Salas I, Castro N, Nuciforo P, Mateo J, Barba I, Perez-Lopez R*; [Magnetic Resonance in Medicine 2022 (epub ahead of print)](https://doi.org/10.1002/mrm.29174), doi: 10.1002/mrm.29174.

This project has received funding from the postdoctoral fellowships programme Beatriu de Pinós (2020 BP 00117), funded by the Secretary of Universities and Research (Government of Catalonia).

![GenCatFund](https://github.com/fragrussu/MChepato/blob/master/funder.png)


## License
This repository is distributed under the Attribution-ShareAlike 4.0 International license ([CC BY-SA 4.0](https://creativecommons.org/licenses/by-sa/4.0/)). Copyright (c) 2022, Fundació Privada Institut d’Investigació Oncològica de Vall d’Hebron. All rights reserved. [Link](https://github.com/fragrussu/MChepato/blob/main/LICENSE.txt) to license. 

**The use of MChepato MUST also comply with the individual licenses of all of its dependencies.**

## Funding
**FG has received funding from the postdoctoral fellowships programme Beatriu de Pinós (2020 BP 00117), funded by the Secretary of Universities and Research (Government of Catalonia).** This project was also supported by Fundació La Caixa and by the investigator-initiated PREdICT study at the Vall d'Hebron Institute of Oncology (Barcelona), funded by AstraZeneca and supporting FG. KB is funded by a Beatriu de Pinós post-doctoral grant (2019 BP 00182). RPL is supported by a CRIS Foundation Talent Award (TALENT19-05), the Instituto de Salud Carlos III-Investigación en Salud (PI18/01395), Spanish Ministry for Science, Innovation and Universities (RTI2018-095209-B-C21, FIS-G64384969), Prostate Cancer Foundation Young Investigator Award and Fero Foundation. ICS is supported by a fellowship from Fundació ”la Caixa” (ID 100010434) and the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 847648, fellowship code LCF/BQ/PI20/1176003.


## Discolsures
FG was supported by PREdICT, a study funded by AstraZeneca at the Vall d’Hebron Institute of Oncology (Barcelona, Spain). There are no conflicts of interest: AstraZeneca was not involved in any aspect concerning this study; it has not influenced the analysis of the data, the interpretation of the results, and the decision to submit the manuscript for publication.
